TY - JOUR
T1 - Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis
AU - The Japanese Research Committee on Severe Cutaneous Adverse Reaction
AU - Kinoshita, Fumie
AU - Yokota, Isao
AU - Mieno, Hiroki
AU - Ueta, Mayumi
AU - Bush, John
AU - Kinoshita, Shigeru
AU - Sueki, Hirohiko
AU - Asada, Hideo
AU - Morita, Eishin
AU - Fukushima, Masanori
AU - Sotozono, Chie
AU - Teramukai, Satoshi
AU - Abe, Riichiro
AU - Hashizume, Hideo
AU - Kurosawa, Michiko
AU - Miyagawa, Fumi
AU - Mushiroda, Taisei
AU - Niihara, Hiroyuki
AU - Nomura, Takashi
AU - Ohyama, Manabu
AU - Takahashi, Hayato
AU - Tohyama, Mikiko
AU - Watanabe, Hideaki
AU - Yamaguchi, Yukie
N1 - Funding Information:
Funding: This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor and Welfare (https://www.mhlw.go.jp/english, 20FC1035), a research Grant from the Japan Agency for Medical Research and Development(https://www.amed.go. jp/en/, 19ek0109377h, 20ek0109377), and a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology(https://www.mext.go.jp/en/, 19H03809). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2021 Kinoshita et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2021/12
Y1 - 2021/12
N2 - This study aimed to clarify the etiologic factors predicting acute ocular progression in SJS/ TEN, and identify patients who require immediate and intensive ophthalmological treatment. We previously conducted two Japanese Surveys of SJS/TEN (i.e., cases arising between 2005–2007 and between 2008–2010), and obtained the medical records, including detailed dermatological and ophthalmological findings, of 230 patients. Acute ocular severity was evaluated as none, mild, severe, and very severe. A multi-state model assuming the Markov process based on the Cox proportional hazards model was used to elucidate the specific factors affecting the acute ocular progression. Our findings revealed that of the total 230 patients, 23 (24%) of 97 cases that were mild at initial presentation worsened to severe/very severe. Acute ocular progression developed within 3 weeks from disease onset. Exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) and younger patient age were found to be statistically significant for the progression of ocular severity from mild to severe/very severe [hazard ratio (HR) 3.83; 95% confidence interval (CI) 1.48 to 9.91] and none to severe/very severe [HR 0.98; 95% CI 0.97 to 0.99], respectively. The acute ocular severity score at worst-condition was found to be significantly correlated with ocular sequelae. Thus, our detailed findings on acute ocular progression revealed that in 24% of SJS/TEN cases with ocular involvement, ocular severity progresses even after initiating intensive treatment, and that in younger-age patients with a history of exposure to NSAIDs, very strict attention must be given to their ophthalmological appearances.
AB - This study aimed to clarify the etiologic factors predicting acute ocular progression in SJS/ TEN, and identify patients who require immediate and intensive ophthalmological treatment. We previously conducted two Japanese Surveys of SJS/TEN (i.e., cases arising between 2005–2007 and between 2008–2010), and obtained the medical records, including detailed dermatological and ophthalmological findings, of 230 patients. Acute ocular severity was evaluated as none, mild, severe, and very severe. A multi-state model assuming the Markov process based on the Cox proportional hazards model was used to elucidate the specific factors affecting the acute ocular progression. Our findings revealed that of the total 230 patients, 23 (24%) of 97 cases that were mild at initial presentation worsened to severe/very severe. Acute ocular progression developed within 3 weeks from disease onset. Exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) and younger patient age were found to be statistically significant for the progression of ocular severity from mild to severe/very severe [hazard ratio (HR) 3.83; 95% confidence interval (CI) 1.48 to 9.91] and none to severe/very severe [HR 0.98; 95% CI 0.97 to 0.99], respectively. The acute ocular severity score at worst-condition was found to be significantly correlated with ocular sequelae. Thus, our detailed findings on acute ocular progression revealed that in 24% of SJS/TEN cases with ocular involvement, ocular severity progresses even after initiating intensive treatment, and that in younger-age patients with a history of exposure to NSAIDs, very strict attention must be given to their ophthalmological appearances.
UR - http://www.scopus.com/inward/record.url?scp=85122036083&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122036083&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0260730
DO - 10.1371/journal.pone.0260730
M3 - Article
C2 - 34941887
AN - SCOPUS:85122036083
SN - 1932-6203
VL - 16
JO - PloS one
JF - PloS one
IS - 12 December
M1 - e0260730
ER -